Clinical trial
Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With…
NCT00220272 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00220272 |
|---|---|
| Title | Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease |
| Official title | A Phase II, Randomized, Multicenter, Multinational, Double-Blind, Placebo-Controlled, Study of the Effect of SR57667B on Dopaminergic Nigro-Striatal Function Assessed by 18F-Dopa PET Imaging in Outpatients With Early Parkinson's Disease |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | SR57667B |
| Enrollment | 183 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 23, 2008 |
| Countries | Canada, Finland, France, Netherlands, Spain, Switzerland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: